
Hydroxychloroquine pre-exposure prophylaxis for COVID-19 among healthcare workers: Initial experience from India
Author(s) -
Harshith B Kadnur,
Anivita Aggarwal,
Manish Soneja,
Komal Singh,
Ankit Mittal,
Neeraj Nischal,
Praveen Tirlangi,
Ajmal Khan,
Devashish Desai,
Ankesh Gupta,
Arvind Kumar,
Pankaj Jorwal,
Ashutosh Biswas,
Ravindra Mohan Pandey,
Naveet Wig,
Randeep Guleria
Publication year - 2022
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_1177_21
Subject(s) - medicine , hydroxychloroquine , adverse effect , discontinuation , confidence interval , incidence (geometry) , common terminology criteria for adverse events , observational study , hazard ratio , covid-19 , disease , physics , infectious disease (medical specialty) , optics
Hydroxychloroquine (HCQ) had generated considerable interest for coronavirus disease 2019 (COVID-19) prophylaxis. We conducted a prospective observational study at a tertiary care hospital in India, with dedicated COVID-19 care facilities.